{
  "id": "clinical#screening_cues_90b98a74",
  "content": "(18,19). The study was conducted in 14 countries – Brazil, Canada, China, Egypt, India, Italy,\nJapan, Lebanon, Mexico, Nigeria, the Russian Federation, South Africa, Spain and Tunisia – via a\nnetwork of international field study centres. The study assessed the reliability and clinical utility\nof the CDDR for disorders that account for the highest percentage of global disease burden and\nuse of mental health services in clinical settings among adults: schizophrenia and other psychotic\ndisorders, mood disorders, anxiety and fear-related disorders, and disorders specifically\nassociated with stress. A joint-rater reliability methodology, in which two clinicians were present\nduring the patient interview but reported their diagnostic formulation and clinical utility ratings\nIntroduction 7\nindependently, was employed in order to isolate the effects of the CDDR from other sources of\nvariance in diagnosis (e.g. changes over time, inconstancy in reporting). Importantly, the level\nof training on the ICD-11 CDDR received by participating clinicians was similar to what might\nbe expected in routine clinical setting during ICD-11 implementation. Clinicians were given no\ninstructions on how to conduct their diagnostic interviews other than to assess the areas that\nwere required as part of the study protocol. Overall, intraclass kappa coefficients (a measure of",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "study",
      "work",
      "habits",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues (18,19). The study was conducted in 14 countries – Brazil, Canada, China, Egypt, India, Italy,\nJapan, Lebanon, Mexico, Nigeria, the Russian Federation, South Africa, Spain and Tunisia – via a\nnetwork of international field study centres. The study assessed the reliability and clinical utility\nof the CDDR for disorders that account for the highest percentage of global disease burden and\nuse of mental health services in clinical settings among adults: schizophrenia and other psychotic\ndisorders, mood disorders, anxiety and fear-related disorders, and disorders specifically\nassociated with stress. A joint-rater reliability methodology, in which two clinicians were present\nduring the patient interview but reported their diagnostic formulation and clinical utility ratings\nIntroduction 7\nindependently, was employed in order to isolate the effects of the CDDR from other sources of\nvariance in diagnosis (e.g. changes over time, inconstancy in reporting). Importantly, the level\nof training on the ICD-11 CDDR received by participating clinicians was similar to what might\nbe expected in routine clinical setting during ICD-11 implementation. Clinicians were given no\ninstructions on how to conduct their diagnostic interviews other than to assess the areas that\nwere required as part of the study protocol. Overall, intraclass kappa coefficients (a measure of (18,19). the học tập was conducted in 14 countries – brazil, canada, china, egypt, india, italy,\njapan, lebanon, mexico, nigeria, the russian federation, south africa, spain and tunisia – via a\nnetwork of international f..."
}